Status:
COMPLETED
Ciprofloxacin on Burned Patients
Lead Sponsor:
Bayer
Conditions:
Burns
Bacterial Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This was a non randomised, multi center, italian study performed in burn patients receiving an antibiotic (ciprofloxacin) in order to treat an active infection. The aim of the study was to validate a ...
Eligibility Criteria
Inclusion
- Moderate to severe burnt patients defined as burning of 20 to 60% of total body surface according to rule of nine, II deep degree and III degree according to Full-Thickness Burn model,
- Hospitalization for burning injury since at least 72h during hyper metabolic phase
- Active infections microbiological confirmed
- Signed informed consent
Exclusion
- Pregnant or lactating female patients
- Previous history of tendinopathy
- Knowing syndrome of QTc prolongation
- Impairment renal function
- Hepatic insufficiency
- Convulsion
- Limited life expectancy
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2003
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00668044
Start Date
November 1 2002
End Date
November 1 2003
Last Update
October 27 2009
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Cesena, Forlì, Italy, 47023
2
Catania, Italy, 95126
3
Genova, Italy, 16132
4
Genova, Italy, 16149